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and US projects focused on developing of methodology for mod-
eling toxicity of nanoparticles, including those conducted within
the European NanoSafety Cluster and the COST MODENA action,
we are now at the stage of collecting ﬁrst results and conclu-
sions. The most important results and reﬂections on the further
development of computational tools for nanotoxicology will be
presented and discussed during the talk. Since calibration and
validation of the computational models are impossible without
mutual understanding and close collaboration with experimental
groups delivering high quality toxicity data, the participation of
experimental toxicologists in the talk and discussion is strongly
encouraged.
http://dx.doi.org/10.1016/j.toxlet.2015.08.093
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Oxidative stress is considered to be a major paradigm to explain
NP toxicity. Here we focused on protein carbonylation as a conse-
quence of oxidative stress for a set of 25 different nanoparticles,
used as either plane (“pristine”) materials or with different sur-
face coatings. In parallel several in vitro and in vivo toxicity
endpoints have been analyzed. We used well characterized NP
of 10nm (ZrO2), 15nm (SiO2) and 50 or 200nm (Ag), furnished
either with acidic, basic or polymeric functionalities. In addition
TiO2(NM-103,-104,-105), ZnO (NM-110, -111), CNT (NM-400, -
401, -402), SiO2 (NM-200, -203, Ag (NM-300K) BaSO4 (NM-220)
and AlOOH were analyzed. In a screening approach we studied
time- and dose-dependent carbonylation of all NP in NRK-52E
cells via 1D immunoblots. Data were correlated with cytotoxic-
ity (WST-8, LDH assay), ROS formation (DCFDA assay) and surface
reactivity (ESR spectroscopy).We applied a 2D-MALDI-MS/MSpro-
teomics approach to identify the modiﬁed proteins. For selected
NP we also analyzed lung tissues homogenates after intratra-
cheal instillation into rat lungs. In parallel we used proteomics
approaches to characterize the NP protein corona in serum as
well as in puriﬁed native surfactant from pig lungs. Twelve out
of 25 NP induced protein carbonylation in NRK-52E cells. The
degree of protein carbonylation correlatedwellwith overall in vitro
toxicity. The 2D approach revealed a complex and distinct pat-
tern of carbonyls. Modiﬁed proteins were identiﬁed as proteins
of cytoskeleton, HSP, or proteins of major cellular pathways (i.e.
glycolysis). Carbonyl modiﬁcations occurred also in lung tissue
homogenates, indicating the relevance of in vitro ﬁndings. Analysis
of poteomics data with hierachical cluster analysis and princi-
pal component analysis revealed differential results for the NM
with respect to induced carbonyl patterns. Taken together, analy-
sis of protein carbonylation appears useful to describe toxic effects
of NP and to better understand underlying molecular mecha-
nisms of toxicity. Furthermore, proteomics data can support NM
classiﬁcation.
http://dx.doi.org/10.1016/j.toxlet.2015.08.094
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Within the Safe by Design concept, the functionality of a material
and its toxicity are considered in an integrated way. The central
goal of this presentation is to discuss some fundamental principles
of engineered nanomaterials (ENM) interactions with biological
systems relevant to human exposure and biological responses.
Major factors to consider in the ENM safe-by-design approach are
surface modiﬁcation to reduce the potential hazardous properties
of target nanoparticles (NP), compatibility between NP coatings
and their matrix, as well as biopersistence, considering the rele-
vant exposure scenarios across the life cycle of the target NP and
products. This is a cross-disciplinary ﬁeld that needs to identify,
at earlier stages of the ENM R&D process, the physicochemical
properties that may act as good predictors of toxicity, e.g. crystal
structure/reactivity, zeta potential/surface charge/dynamic prop-
erties. Furthermore, it is also needed to build adequate screening
in vitro testing strategies (realistic doses, exposure duration and
target tissues), incorporating relevant hazard endpoints that can
give an insight about the toxicological mode of action (MoA) with
relevance to human health and environment, taking into account
the uses and applications along the lifecycle (EHS roadmap). These
topics will be illustrated by a cytotoxicity and genotoxicity study
performed with a set of ENM with identical chemistry but different
physicochemical characteristics that highlighted the importance
of investigating each ENM individually, instead of assuming a
common MoA. The ﬁndings, although creating a dilemma for
developing criteria for categorization and read-across, are also
suggestive of the importance of considering the functionality
of a material and its toxicity in an integrated way, enabling a
safe-by-design concept. Ultimately, the overall safety data is
intended to best support the decision of IND developers and risk
managers during the ENM design and development processes.
http://dx.doi.org/10.1016/j.toxlet.2015.08.095
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Till date, microarray-based technologies represent the main
analytical platform in toxicogenomics. However, where high
throughput sequencing (HTS) methods are technically advancing
and costs for HTS are expected to come down on rather short
